Table 1

Baseline demographics and MRI volumes, stratified by the WMH progression threshold of ≥1.4 mL vs <1.4 mL

VariableFull cohort
(N=433)
WMH progression ≥1.4 mL
(n=156)
WMH progression <1.4 mL
(n=277)
P value*
Age67.3±7.869.7±8.065.9±7.3<0.001
Male sex272 (62.8%)90 (57.7%)182 (65.7%)0.098
Race/ethnicity0.730
White277 (64.0%)97 (62.2%)180 (65.0%)
Black132 (30.5%)52 (33.3%)80 (28.9%)
Hispanic20 (4.6%)6 (3.9%)14 (5.1%)
Other4 (0.9%)1 (0.6%)3 (1.1)
History of cardiovascular disease50 (11.6%)25 (16.0%)25 (9.0%)0.029
History of diabetes9 (2.1%)5 (3.2%)4 (1.4%)0.294
History of peripheral vascular disease24 (5.5%)7 (4.5%)17 (6.1%)0.471
History of atrial fibrillation29 (6.7%)10 (6.4%)19 (6.9%)0.858
Smoking (n=432)0.050
Never197 (45.6%)59 (37.8%)138 (50.0%)
Past180 (41.7%)75 (48.1%)105 (38.0%)
Current55 (12.7%)22 (14.1%)33 (12.0%)
Alcoholism10 (2.3%)3 (1.9%)7 (2.5%)1.000
Vigorous phsycial activities0.817
≤1 /week219 (50.6%)82 (52.6%)137 (49.5%)
1–4/week152 (35.1%)53 (34.0%)99 (35.7%)
≥5 /week62 (14.3%)21 (13.4%)41 (14.8%)
Aspirin use217 (50.1%)85 (54.5%)132 (47.7%)0.172
Retired250 (57.7%)100 (64.1%)150 (54.2%)0.044
Education0.042
<College or other250 (57.7%)101 (64.7%)149 (53.8%)
College69 (16.0%)17 (10.9%)52 (18.9%)
Graduate school114 (26.3%)38 (24.4%)76 (27.4%)
Randomised to intensive blood pressure reduction241 (55.7%)73 (46.8%)168 (60.7%)0.005
Baseline WMH volume (mL)5.8±7.49.7±9.33.6±4.9<0.001
Baseline total intracranial volume (mL)1391±1441397±1461388±1430.558
  • *P value shown for comparison between WMH progression stratification and calculated with Student’s t-test for interval variables and the χ2 or Fisher’s exact test for binary variables, depending on frequency; interval variables shown as mean±SD and binary variables as n (%).

  • WMH, white matter hyperintensity.